IRD
Opus Genetics·NASDAQ
--
--(--)
--
--(--)
6.96 / 10
Outperform
Sentiment scores 6.96 (Outperform) and fund‑flow 7.43 (good), with positive inflows in small, medium and large caps but negative overall and block trends. Analysts are split 50% Strong Buy and 50% Buy; BTIG shows 100% historic win rate, while others lag. Consensus remains bullish.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Andreas ArgyridesBuy
Date2026-03-16
InstitutionOppenheimer
Times predicted1
Historical Win Rate0.0%
Daniil GataulinStrong Buy
Thomas ShraderStrong Buy
Yun ZhongBuy
Is money flowing into or out of IRD?
- IRD holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.96/10 (Outperform).
